Results 101 to 110 of about 38,385 (346)

The Sight Loss and Vision Priority Setting Partnership (SLV-PSP): overview and results of the research prioritisation survey process [PDF]

, 2014
Objectives: The Sight Loss and Vision Priority Setting Partnership aimed to identify research priorities relating to sight loss and vision through consultation with patients, carers and clinicians.
Acton, M, Bonstein, K, Bowen, M, Bronze, C, Bunce, C, Cable, R, Conroy, D, Cowan, K, Evans, K, Fenton, M, Giles, H, Gordon, I, Halfhide, L, Harper, R, Lightstone, A, Rowe, FJ, Votruba, M, Waterman, H, Wormald, R, Zekite, A   +19 more
core   +1 more source

A brief overview of the diabetic neuropathies [PDF]

, 2023
Andrew J.M. Boulton
openalex   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists, Sodium‐Glucose Cotransporter‐2 Inhibitors, and Risk of Autoimmune Rheumatic Diseases

Arthritis &Rheumatology, Accepted Article.
Objective GLP‐1 receptor agonists (GLP‐1RAs) and SGLT2 inhibitors (SGLT2is) facilitate weight loss and exhibit immunomodulatory effects, but their impact on the risk of developing autoimmune rheumatic diseases (ARDs) is unclear. We compared ARD incidence following initiation of GLP‐1RAs, or SGLT2is, vs.
Derin Karacabeyli, Diane Lacaille, Na Lu, Hui Xie, J. Antonio Aviña‐Zubieta   +4 more
wiley   +1 more source

Diabetic neuropathy in children and youth: New and emerging risk factors [PDF]

, 2020
Gülçin Akıncı, Masha G. Savelieff, Gary W. Gallagher, Brian C. Callaghan, Eva L. Feldman   +4 more
openalex   +1 more source

Diabetic Neuropathy Collection: Treatment of Diabetic Neuropathy [PDF]

Diabetes Therapy, 2020
Video: Treatment of Diabetic Neuropathy podcast recording (MP4 61908 kb).
openaire   +2 more sources

The Relationship Between Aldose Reductase and Isoxazole Derivatives: An In Vitro and In Silico Approach to Its Correlation With Diabetic Conditions

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Diabetes mellitus (DM), which can result in a number of problems such as cataracts, neuropathy, retinopathy, nephropathy, and several cardiovascular illnesses, continues to be a growing issue despite major advancements in treatment approaches.
Ahmet Esat Göner, Hatice Esra Duran
wiley   +1 more source

Metformin protects from oxaliplatin induced peripheral neuropathy in rats

Neurobiology of Pain, 2020
Oxaliplatin is a commonly used drug to treat cancer, extending the rate of disease-free survival by 20% in colorectal cancer. However, oxaliplatin induces a disabling form of neuropathy resulting in more than 60% of patients having to reduce or ...
N.W. Martinez, A. Sánchez, P. Diaz, R. Broekhuizen, J. Godoy, S. Mondaca, A. Catenaccio, P. Macanas, B. Nervi, M. Calvo, F.A. Court   +10 more
doaj   +1 more source

Impaired expression of neuronal nitric oxide synthase in the gracile nucleus is involved in neuropathic changes in Zucker Diabetic Fatty rats with and without 2,5-hexanedione intoxication [PDF]

, 2016
These studies examined the influence of 2,5-hexanedione (2,5-HD) intoxication on expression of neuronal nitric oxide synthase (nNOS) in the brainstem nuclei in Zucker Diabetic Fatty (ZDF) vs. lean control (LC) rats.
Lee, Paul, Lee, Wai-Nang Paul, Li, Xi-Yan, Ma, Sheng-Xing, Magee, Edward M., Peterson, Richard G.   +5 more
core   +1 more source

Diabetic Neuropathy Collection: Introduction to Diabetic Neuropathy [PDF]

Diabetes Therapy, 2020
Introduction to Diabetic Neuropathy podcast recording (MP4 55526 kb).
openaire   +2 more sources

Cost–benefit analysis of screening programme for diabetic retinopathy in Bulgaria

British Journal of Clinical Pharmacology, EarlyView.
Aims Late‐diagnosed diabetic retinopathy (DR) is difficult and expensive to treat. Screening programmes can identify the disease early and reduce the costs of its future treatment. This study aims to analyse the cost–benefit of screening programmes for DR.
Iva Nenkova, Yoana Lilova, Alexander Oscar, Alina Levi, Maria Kamusheva, Guenka Petrova   +5 more
wiley   +1 more source